Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giacomo Boffa

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Psychology, Health & Medicine|April 26, 2021
Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemicElvira Sbragia, Eleonora Colombo, Chiara Pollio, et al.
CNS Drugs|March 21, 2020
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS PopulationGiacomo Boffa, Nicolò Bruschi, Maria Cellerino, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 14, 2024
Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosisVincenzo Daniele Boccia, Giacomo Boffa, Caterina Lapucci, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2020
Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three casesGiacomo Boffa, Elvira Sbragia, Anna Maria Raiola, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2023
An aggressive form of MOGAD treated with aHSCT: A case reportElvira Sbragia, Giacomo Boffa, Riccardo Varaldo, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 5, 2021
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple SclerosisMaria Cellerino, Luca Priano, Nicolò Bruschi, et al.
Human Vaccines & Immunotherapeutics|July 21, 2022
Vaccinations in patients with multiple sclerosis: a real-world, single-center experienceElvira Sbragia, Dario Olobardi, Giovanni Novi, et al.
Developmental Medicine and Child Neurology|December 3, 2016
A diffusion tensor magnetic resonance imaging study of paediatric patients with severe non-traumatic brain injuryErika Molteni, Maria A Rocca, Sandra Strazzer, et al.
Multiple Sclerosis and Related Disorders|August 24, 2025
The early effect of induction versus continuous therapies in active multiple sclerosis: a multimodal study on the first course of cladribine versus fingolimodTommaso Sirito, Emilio Cipriano, Caterina Lapucci, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 31, 2025
Cognitive changes in patients with relapse-free MS treated with high efficacy therapies: the predictive value of paramagnetic rim lesionsVincenzo Daniele Boccia, Elisa Leveraro, Emilio Cipriano, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Psychology, Health & Medicine|April 26, 2021
Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemicElvira Sbragia, Eleonora Colombo, Chiara Pollio, et al.
CNS Drugs|March 21, 2020
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS PopulationGiacomo Boffa, Nicolò Bruschi, Maria Cellerino, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 14, 2024
Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosisVincenzo Daniele Boccia, Giacomo Boffa, Caterina Lapucci, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2020
Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three casesGiacomo Boffa, Elvira Sbragia, Anna Maria Raiola, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2023
An aggressive form of MOGAD treated with aHSCT: A case reportElvira Sbragia, Giacomo Boffa, Riccardo Varaldo, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 5, 2021
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple SclerosisMaria Cellerino, Luca Priano, Nicolò Bruschi, et al.
Human Vaccines & Immunotherapeutics|July 21, 2022
Vaccinations in patients with multiple sclerosis: a real-world, single-center experienceElvira Sbragia, Dario Olobardi, Giovanni Novi, et al.
Developmental Medicine and Child Neurology|December 3, 2016
A diffusion tensor magnetic resonance imaging study of paediatric patients with severe non-traumatic brain injuryErika Molteni, Maria A Rocca, Sandra Strazzer, et al.
Multiple Sclerosis and Related Disorders|August 24, 2025
The early effect of induction versus continuous therapies in active multiple sclerosis: a multimodal study on the first course of cladribine versus fingolimodTommaso Sirito, Emilio Cipriano, Caterina Lapucci, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 31, 2025
Cognitive changes in patients with relapse-free MS treated with high efficacy therapies: the predictive value of paramagnetic rim lesionsVincenzo Daniele Boccia, Elisa Leveraro, Emilio Cipriano, et al.
Pageof 5